Xenous Holdings Reports $760M Capital Deficiency, Remains Blank Check
Ticker: XITO · Form: 10-K · Filed: Jun 27, 2025 · CIK: 1651932
| Field | Detail |
|---|---|
| Company | Xenous Holdings, Inc. (XITO) |
| Form Type | 10-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: Blank Check Company, Capital Deficiency, No Revenue, OTC Pink Sheet, High Risk, Shell Company, Financial Distress
TL;DR
**XITO is a zombie blank check with a massive capital hole; avoid at all costs.**
AI Summary
Xenous Holdings, Inc. (XITO) filed its 10-K for the fiscal year ended March 31, 2025, revealing a significant capital deficiency of $760,250,000 as of March 31, 2025, a substantial increase from the prior year. The company reported no revenue for the fiscal year, consistent with its classification as a 'Blank Checks' entity. Net income was not explicitly stated but implied to be negative given the capital deficiency. Key business changes include the continued operation as a shell company, with no active business operations or revenue-generating activities. Risks are primarily associated with its status as a blank check company, including the inability to complete a business combination and the potential for delisting from the OTC Pink Sheet. The strategic outlook remains focused on identifying and acquiring an operating business, as indicated by its historical SIC code 6770.
Why It Matters
Xenous Holdings' persistent blank check status and a staggering $760.25 million capital deficiency as of March 31, 2025, signal extreme risk for investors, indicating no operational business or revenue. This lack of progress in securing a business combination puts employees and customers at zero risk, as there are none. In a competitive market for SPACs and blank check companies, XITO's prolonged dormancy and financial state make it an unattractive target for potential merger partners, highlighting its failure to execute its core purpose. The broader market impact is minimal due to its OTC Pink Sheet listing and lack of active operations.
Risk Assessment
Risk Level: high — The risk level is high due to the company's classification as a 'Blank Checks' entity (SIC code 6770) with no revenue and a substantial capital deficiency of $760,250,000 as of March 31, 2025. This indicates a complete lack of operational business and significant financial distress, making it highly speculative.
Analyst Insight
Investors should avoid Xenous Holdings (XITO) given its blank check status, lack of revenue, and a $760.25 million capital deficiency. This filing provides no evidence of a viable business or path to profitability, making it an extremely high-risk, speculative investment.
Financial Highlights
- debt To Equity
- Not Explicitly Stated
- revenue
- $0
- operating Margin
- N/A
- total Assets
- Not Explicitly Stated
- total Debt
- Not Explicitly Stated
- net Income
- Not Explicitly Stated (Implied Negative)
- eps
- Not Explicitly Stated
- gross Margin
- N/A
- cash Position
- Not Explicitly Stated
- revenue Growth
- N/A
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Core Operations | $0 | N/A |
Key Numbers
- $760.25M — Capital Deficiency (Increased significantly as of March 31, 2025, indicating severe financial distress.)
- $0 — Revenue (No revenue reported for the fiscal year ended March 31, 2025, consistent with a blank check company.)
- 000-55512 — Commission File Number (Identifies the company's filing with the SEC.)
- 6770 — SIC Code (Indicates the company's classification as a 'Blank Checks' entity.)
Key Players & Entities
- Xenous Holdings, Inc. (company) — registrant
- Smartex Investment Ltd (company) — related entity mentioned in financial statements
- SEC (regulator) — filing oversight
- Nevada (regulator) — state of incorporation
- OTC Pink Sheet (regulator) — securities exchange
- $760,250,000 (dollar_amount) — capital deficiency as of March 31, 2025
- 000-55512 (regulator) — Commission file number
- 6770 (regulator) — Standard Industrial Classification (Blank Checks)
FAQ
What is Xenous Holdings, Inc.'s primary business activity?
Xenous Holdings, Inc. (XITO) is classified under SIC code 6770, indicating it is a 'Blank Checks' company. This means its primary business activity is to identify and acquire an operating business, rather than conducting its own operations.
What was Xenous Holdings, Inc.'s revenue for the fiscal year ended March 31, 2025?
Xenous Holdings, Inc. reported no revenue for the fiscal year ended March 31, 2025, consistent with its status as a blank check company that has not yet completed a business combination.
What is the capital deficiency reported by Xenous Holdings, Inc.?
As of March 31, 2025, Xenous Holdings, Inc. reported a significant capital deficiency of $760,250,000, indicating a substantial negative equity position.
Where is Xenous Holdings, Inc. incorporated?
Xenous Holdings, Inc. is incorporated in Nevada, as stated in its 10-K filing.
What exchange are Xenous Holdings, Inc. securities registered on?
Xenous Holdings, Inc. securities are registered pursuant to Section 12(g) of the Act on the OTC Pink Sheet.
What are the main risks associated with investing in Xenous Holdings, Inc.?
The main risks include its status as a blank check company with no operations or revenue, a substantial capital deficiency of $760.25 million, and the inherent uncertainty of completing a business combination, which could lead to a loss of investment.
Has Xenous Holdings, Inc. changed its name recently?
Yes, Xenous Holdings, Inc. was formerly known as M101 CORP. until November 3, 2017, and before that, Concept Holding Corp. until August 27, 2015.
What is the fiscal year end for Xenous Holdings, Inc.?
The fiscal year end for Xenous Holdings, Inc. is March 31, as indicated by the 'CONFORMED PERIOD OF REPORT: 20250331' in the filing.
What is the business address of Xenous Holdings, Inc.?
The business address of Xenous Holdings, Inc. is Room 1120, 11th Floor, Peninsula Centre, 67 Mody Road, Tsim Sha Tsui, East Kowloon, Hong Kong.
Is Xenous Holdings, Inc. considered a well-known seasoned issuer?
No, Xenous Holdings, Inc. indicated by check mark that it is not a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Risk Factors
- Significant Capital Deficiency [high — financial]: The company reported a substantial capital deficiency of $760,250,000 as of March 31, 2025. This represents a significant increase from the prior year and indicates severe financial distress, raising concerns about the company's ability to continue as a going concern without further capital infusion or a successful business combination.
- Lack of Revenue and Operations [high — operational]: Xenous Holdings, Inc. reported $0 in revenue for the fiscal year ended March 31, 2025. This is consistent with its status as a blank check company with no active business operations. The absence of revenue generation poses a fundamental risk to the company's long-term viability.
- Inability to Complete Business Combination [high — regulatory]: As a blank check company, Xenous Holdings, Inc.'s primary objective is to identify and acquire an operating business. Failure to complete a business combination within the required timeframe could lead to the dissolution of the company and potential delisting from the OTC Pink Sheet, resulting in a loss for shareholders.
- Delisting Risk [medium — market]: The company's securities are traded on the OTC Pink Sheet. Continued lack of operational progress or failure to meet listing requirements could result in delisting, significantly reducing liquidity and market access for investors.
Industry Context
The blank check company sector, often categorized under SIC Code 6770, is characterized by entities formed to facilitate mergers, acquisitions, or similar business combinations. These companies typically have no revenue-generating operations and rely on identifying a suitable target business. The competitive landscape involves numerous special purpose acquisition companies (SPACs) and other shell entities vying to complete transactions, often facing regulatory scrutiny and market volatility.
Regulatory Implications
As a blank check company, Xenous Holdings, Inc. is subject to specific regulatory requirements, particularly concerning the timeline for completing a business combination. Failure to do so can lead to dissolution and potential delisting. The company's status also means it faces scrutiny regarding its ability to identify and execute a viable acquisition strategy that creates shareholder value.
What Investors Should Do
- Monitor progress on business combination efforts.
- Assess the company's ability to secure additional capital.
- Evaluate the risks associated with OTC Pink Sheet listing.
Key Dates
- 2025-03-31: Fiscal Year End — Marks the end of the reporting period for which the 10-K was filed, revealing a significant capital deficiency and no revenue.
- 2025-06-27: 10-K Filing Date — The date Xenous Holdings, Inc. filed its annual report, providing the latest financial and operational details to investors and the SEC.
Glossary
- Blank Checks Entity
- A company that is formed with the sole purpose of raising capital through an initial public offering (IPO) to acquire an existing company. These companies typically have no active business operations at the time of their IPO. (Xenous Holdings, Inc. is classified under SIC Code 6770, indicating its status as a blank check company, which dictates its business strategy and associated risks.)
- Capital Deficiency
- A situation where a company's liabilities exceed its assets, resulting in a negative net worth. This indicates a severe financial imbalance. (Xenous Holdings, Inc. reported a substantial capital deficiency of $760,250,000 as of March 31, 2025, highlighting its precarious financial condition.)
- SIC Code 6770
- The Standard Industrial Classification code for 'Blank Checks' companies, used to categorize businesses based on their primary activity. (This code confirms Xenous Holdings, Inc.'s nature as a shell company focused on future acquisitions rather than current operations.)
- OTC Pink Sheet
- A quotation service for over-the-counter (OTC) securities, often used by smaller companies that do not meet the listing requirements of major stock exchanges. (Xenous Holdings, Inc. is listed on the OTC Pink Sheet, and risks associated with this market, such as potential delisting, are significant.)
Year-Over-Year Comparison
The fiscal year ended March 31, 2025, shows a stark financial deterioration for Xenous Holdings, Inc. compared to the prior year. Most notably, the company reported $0 in revenue for the current fiscal year, consistent with its blank check status, but the capital deficiency has ballooned to $760,250,000, indicating a severe worsening of its financial position. No specific revenue growth or margin changes can be assessed due to the lack of revenue in both periods, but the increased capital deficiency highlights heightened financial distress and operational risk.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on June 27, 2025 regarding Xenous Holdings, Inc. (XITO).